AMUNDI ASSET MANAGEMENT US, INC. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 43 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
AMUNDI ASSET MANAGEMENT US, INC. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$8,889,000
-30.0%
9,220,000
-31.1%
0.01%
-36.4%
Q4 2020$12,698,000
+8.6%
13,390,000
+5.5%
0.01%
-8.3%
Q3 2020$11,688,000
+268.9%
12,690,000
+252.5%
0.01%
+200.0%
Q2 2020$3,168,000
+9.6%
3,600,0000.0%0.00%
-20.0%
Q1 2020$2,891,000
-30.6%
3,600,000
-21.7%
0.01%0.0%
Q4 2019$4,164,000
+1025.4%
4,600,000
+1050.0%
0.01%
+400.0%
Q3 2019$370,000
-69.5%
400,000
-67.9%
0.00%0.0%
Q2 2019$1,215,0001,245,0000.00%
Other shareholders

There were no reported owners of SUPERNUS PHARMACEUTICALS INC in Q3 2020.

NameSharesValueWeighting ↓
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders